Correction: Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut (Proc Natl Acad Sci USA (2014) 111, 44 (15821-15826) DOI: 10.1073/pnas.1409078111);Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 44, 2014, Pages 15821-15826

  Durnin, Leonie ^a   Hwang, Sung Jin ^a   Kurahashi, Masaaki ^a   Drumm, Bernard T ^a   Ward, Sean M ^a   Sasse, Kent C ^b   Sers, Kenton M ^a   Mutafova Yambolieva, Violeta N ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b Sasse Surgical Associates   (United States)

Author keywords

Enteric nervous system; Intestine; P2Y1 receptor; Purinergic signaling; Up4A

Indexed keywords

4 (2 IODO 6 METHYLAMINO 9H PURIN 9 YL) 2 PHOSPHONOOXYBICYCLO[3.1.0]HEXANE 1 METHANOL; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE TRIPHOSPHATE; APAMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PURINERGIC P2Y RECEPTOR AGONIST; PURINERGIC P2Y1 RECEPTOR; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; SURAMIN; TETRODOTOXIN; UNCLASSIFIED DRUG; URIDINE; URIDINE ADENOSINE TETRAPHOSPHATE; URIDINE DIPHOSPHATE; URIDINE PHOSPHATE; 2-IODO-N(6)-METHYL-(N)-METHANOCARBA-2'-DEOXYADENOSINE-3',5'-BISPHOSPHATE; ANTINEOPLASTIC AGENT; DEOXYADENOSINE PHOSPHATE; DINUCLEOSIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; ASTROCYTOMA CELL; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; CATABOLISM; CLINICAL ARTICLE; COLON MOTILITY; CONTROLLED STUDY; DESCENDING COLON; DRUG POTENCY; ENZYME METABOLISM; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPERPOLARIZATION; INTESTINE CONTRACTION; INTESTINE MUSCLE; MEMBRANE POTENTIAL; MOUSE; MUSCLE RELAXATION; NERVE CELL; NERVE STIMULATION; NEUROTRANSMISSION; NONHUMAN; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; ANIMAL; COLON; DRUG EFFECTS; GASTROINTESTINAL MOTILITY; GENETICS; INNERVATION; KNOCKOUT MOUSE; METABOLISM; SMOOTH MUSCLE;

MURINAE; MUS;

ADENOSINE DIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; COLON; DEOXYADENINE NUCLEOTIDES; DINUCLEOSIDE PHOSPHATES; GASTROINTESTINAL MOTILITY; HUMANS; MICE; MICE, KNOCKOUT; MUSCLE RELAXATION; MUSCLE, SMOOTH; PURINERGIC P2Y RECEPTOR AGONISTS; RECEPTORS, PURINERGIC P2Y1; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; SURAMIN; URIDINE DIPHOSPHATE;

EID: 84914696709     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1421401112     Document Type: Erratum

References (29)

1. Jankowski V, et al. (2005) Uridine adenosine tetraphosphate: A novel endotheliumderived vasoconstrictive factor. Nat Med 11(2):223-227.
2. Jankowski V, et al. (2008) Uridine adenosine tetraphosphate acts as an autocrine hormone affecting glomerular filtration rate. J Mol Med (Berl) 86(3):333-340.
3. Jankowski V, et al. (2007) Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives. Arterioscler Thromb Vasc Biol 27(8):1776-1781.
4. Matsumoto T, Tostes RC, Webb RC (2011) Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 301(2):H409-H417.
5. Matsumoto T, Watanabe S, Kawamura R, Taguchi K, Kobayashi T (2014) Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis. Pflugers Arch 466(2):331-342.
6. Gui Y, et al. (2011) Uridine adenosine tetraphosphate induces contraction of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 301(5):L789-L794.
7. Yuan W, et al. (2013) Uridine adenosine tetraphosphate induces contraction of circular and longitudinal gastric smooth muscle by distinct signaling pathways. IUBMB Life 65(7):623-632.
8. Tölle M, et al. (2010) Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol 161(3):530-540.
9. Zhou Z, et al. (2013) Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors. Pharmacol Res 67(1):10-17.
10. Wiedon A, et al. (2012) Uridine adenosine tetraphosphate (Up4A) is a strong inductor of smooth muscle cell migration via activation of the P2Y2 receptor and cross-communication to the PDGF receptor. Biochem Biophys Res Commun 417(3):1035-1040.
11. Schepers E, et al. (2010) Dinucleoside polyphosphates: Newly detected uraemic compounds with an impact on leucocyte oxidative burst. Nephrol Dial Transplant 25(8):2636-2644.
12. Schuchardt M, et al. (2011) The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. J Mol Med (Berl) 89(8):799-810.
13. Gallego D, Hernández P, Clavé P, Jiménez M (2006) P2Y1 receptors mediate inhibitory purinergic neuromuscular transmission in the human colon. Am J Physiol Gastrointest Liver Physiol 291(4):G584-G594.
14. Mutafova-Yambolieva VN, et al. (2007) Beta-nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle. Proc Natl Acad Sci USA 104(41): 16359-16364.
15. Hwang SJ, et al. (2011) β-nicotinamide adenine dinucleotide is an enteric inhibitory neurotransmitter in human and nonhuman primate colons. Gastroenterology 140(2): 608-617, e6.
16. Hwang SJ, et al. (2012) P2Y1 purinoreceptors are fundamental to inhibitory motor control of murine colonic excitability and transit. J Physiol 590(Pt 8):1957-1972.
17. Durnin L, Hwang SJ,Ward SM, Sanders KM, Mutafova-Yambolieva VN (2012) Adenosine 5-diphosphate-ribose is a neural regulator in primate and murine large intestine along with β-NAD(+). J Physiol 590(Pt 8):1921-1941.
18. Banks BE, et al. (1979) Apamin blocks certain neurotransmitter-induced increases in potassium permeability. Nature 282(5737):415-417.
19. Costa M, Furness JB, Humphreys CM (1986) Apamin distinguishes two types of relaxation mediated by enteric nerves in the guinea-pig gastrointestinal tract. Naunyn Schmiedebergs Arch Pharmacol 332(1):79-88.
20. Burnstock G (2008) The journey to establish purinergic signalling in the gut. Neurogastroenterol Motil 20(Suppl 1):8-19.
21. Durnin L, Sanders KM, Mutafova-Yambolieva VN (2013) Differential release of β-NAD(+) and ATP upon activation of enteric motor neurons in primate and murine colons. Neurogastroenterol Motil 25(3):e194-e204.
22. Mutafova-Yambolieva VN, Durnin L (2014) The purinergic neurotransmitter revisited: A single substance or multiple players? Pharmacol Ther 144(2):162-191.
23. Bobalova J, Bobal P, Mutafova-Yambolieva VN (2002) High-performance liquid chromatographic technique for detection of a fluorescent analogue of ADP-ribose in isolated blood vessel preparations. Anal Biochem 305(2):269-276.
24. Kurahashi M, et al. (2011) A functional role for the 'fibroblast-like cells' in gastrointestinal smooth muscles. J Physiol 589(Pt 3):697-710.
25. Spencer NJ, Bywater RA, Holman ME, Taylor GS (1998) Inhibitory neurotransmission in the circular muscle layer of mouse colon. J Auton Nerv Syst 70(1-2):10-14.
26. Peri LE, Sanders KM, Mutafova-Yambolieva VN (2013) Differential expression of genes related to purinergic signaling in smooth muscle cells, PDGFRα-positive cells, and interstitial cells of Cajal in the murine colon. Neurogastroenterol Motil 25(9): e609-e620.
27. Brunschweiger A, Müller CE (2006) P2 receptors activated by uracil nucleotides-an update. Curr Med Chem 13(3):289-312.
28. Smyth LM, Bobalova J, Mendoza MG, Lew C, Mutafova-Yambolieva VN (2004) Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder. J Biol Chem 279(47):48893-48903.
29. Schachter JB, Li Q, Boyer JL, Nicholas RA, Harden TK (1996) Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br J Pharmacol 118(1):167-173.